PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsCarcinoma
MeSH D002277 - carcinoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009375:Glandular and epithelial neoplasms
0 Companies
0 Drugs
Success rate
D002277: 
Carcinoma
18 Companies
3 Drugs
$
Success rate
D000069295:Mammary analogue secretory carcinoma
0 Companies
0 Drugs
Success rate
D000077216:Ovarian epithelial carcinoma
1 Company
1 Drug
$
Success rate
D000077274:Nasopharyngeal carcinoma
1 Company
1 Drug
$
Success rate
D000230:Adenocarcinoma
24 Companies
3 Drugs
$
Success rate
D002278:Carcinoma in situ
0 Companies
0 Drugs
Success rate
D002280:Basal cell carcinoma
29 Companies
2 Drugs
$
Success rate
D002281:Basosquamous carcinoma
0 Companies
0 Drugs
Success rate
D002286:Ehrlich tumor carcinoma
0 Companies
0 Drugs
Success rate
D002287:Krebs 2 carcinoma
0 Companies
0 Drugs
Success rate
D002291:Papillary carcinoma
0 Companies
0 Drugs
Success rate
D002294:Squamous cell carcinoma
18 Companies
8 Drugs
$
Success rate
D002295:Transitional cell carcinoma
8 Companies
8 Drugs
$
Success rate
D018196:Adenosquamous carcinoma
0 Companies
0 Drugs
Success rate
D018286:Giant cell carcinoma
0 Companies
0 Drugs
Success rate
D018287:Large cell carcinoma
0 Companies
0 Drugs
Success rate
D018288:Small cell carcinoma
20 Companies
3 Drugs
$
Success rate
D018289:Verrucous carcinoma
0 Companies
0 Drugs
Success rate
D018827:Lewis lung carcinoma
0 Companies
0 Drugs
Success rate
D065646:Anaplastic thyroid carcinoma
0 Companies
0 Drugs
Success rate
D000093284:Non-muscle invasive bladder neoplasms
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareCarmustine Carmustine  2022-12-27   
Alembic PharmaceuticalsCarmustine Carmustine  2023-10-20   
Amneal PharmaceuticalsCarmustine Carmustine  2018-10-16   
Avet LifesciencesCarmustine Bicnu  1982-01-01   
AzurityCarmustine Gliadel  1996-09-23   
Dr Reddys LaboratoriesCarmustine Carmustine  2020-10-22   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
63%
15/24
Phase 2
22%
8/37
Phase 3
21%
3/14
Approved: 3Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bayer
Diethylstilbestrol,
Transplatin,
Antithrombin iii,
Radium ra-223,
Enoblituzumab,
Aglatimagene besadenovec,
Ademetionine,
Regramostim,
Gadoxetic acid,
Molgramostim,
Sodium chloride,
Aspartame,
Bevifimod,
ORTATAXEL,
REFAMETINIB,
Rogaratinib,
Telbermin,
Edetic acid,
Alpharadin,
Corticoids,
Radium,
Saha,
Caelyx,
Fendrix,
Doxorubin,
Mk3475,
Pd0332991,
Sagramostim,
Sfn,
Bay1163877,
Arm1,
Bsc,
Gemcis,
Hydroxydaunomycin,
Pcd,
Arm2,
Bolus,
Demand,
Docetaxol,
Ra223,
Taxane,
Primovist
Bristol Myers Squibb
Sacituzumab,
Rucaparib,
Benzocaine,
Transplatin,
Rucaparib camsylate,
Antithrombin iii,
Nogapendekin alfa,
Bempegaldesleukin,
Cilmostim,
Linrodostat,
Entinostat,
Epacadostat,
Aglatimagene besadenovec,
Inbakicept,
Guadecitabine,
Galunisertib,
Brivanib alaninate,
Ademetionine,
Vicriviroc,
Glutamic acid,
Doconexent,
Vorhyaluronidase alfa,
SOTIGALIMAB,
VARLILUMAB,
Serine,
Sodium chloride,
Bevifimod,
CABIRALIZUMAB,
EGANELISIB,
LIRILUMAB,
Nepidermin,
URELUMAB,
Vilobelimab,
D-glutamate,
Ag013736,
Foster,
N803,
Tpf,
Endocrine,
Nerofe,
Mk3475,
Q2w,
Vp16,
Hiltonol,
Tcr,
Sbrt,
Tmz,
Arm1,
Bsc,
Gemcis,
Parpi,
Pcd,
Arm2,
Docetaxol,
DNAJB1,
Evidence,
Iclc,
Krn951,
Therasphere
Eli Lilly
Benzocaine,
Docusate,
Transplatin,
Albumin,
Antithrombin iii,
Vitamin e,
Aglatimagene besadenovec,
Pegilodecakin,
Galunisertib,
Ademetionine,
Vicriviroc,
Glutamic acid,
Enzastaurin,
Edrecolomab,
Doconexent,
Pegargiminase,
Sodium chloride,
Bevifimod,
CIXUTUMUMAB,
GATAPARSEN,
ICRUCUMAB,
MERESTINIB,
Nepidermin,
PREXASERTIB,
Sodium iodide i-131,
Telbermin,
Zoptarelin doxorubicin,
Retinol,
D-glutamate,
Vipivotide tetraxetan lutetium lu-177,
Rhtsh,
Caelyx,
Cdp1,
Ly3435151,
Viaject,
Doxorubin,
LY2584702,
Mk3475,
Q2w,
LY2510924,
Vp16,
Pd0332991,
Folinoral,
Sbrt,
Tmz,
Arm1,
Bsc,
Gemcis,
Hydroxydaunomycin,
Arm2,
Bolus,
Docetaxol,
Fluoropyrimidine,
Taxane,
Evidence,
Nvb
Jiangsu Hengrui Medicine
Transplatin,
Albumin,
Antithrombin iii,
Camrelizumab,
Famitinib,
Nimotuzumab,
Adebrelimab,
Ademetionine,
Rivoceranib,
Nedaplatin,
Bevifimod,
Telbermin,
Retinol,
Shr-1316,
Tpf,
Endocrine,
Q2w,
Gemox,
Folinoral,
Sbrt,
Arm1,
Gemcis,
Docetaxol,
Plc,
Shr1210
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use